Kailera Therapeutics · 2 days ago
Internship: Medical Communications
Greater Boston
Internship
Onsite
Intern
$25/hr - $30/hrKailera Therapeutics is dedicated to developing therapies that empower individuals to improve their health. The Medical Communications Internship offers hands-on experience in creating medical communications projects, including publications and educational materials, while collaborating with various stakeholders across the company.
BiotechnologyPharmaceuticalTherapeutics
Responsibilities
Contribute to the planning and development of scientific abstracts and posters
Collaborate with Medical Directors and Medical Science Liaisons to develop educational slide decks approved for external use
Participate in cross-functional congress planning meetings and support the execution of congress deliverables
Develop standard and custom response letters to address medical information queries
Support medical operations in tracking project timelines, maintaining documentation, and ensuring compliance with internal processes
With guidance, lead the development of a medical communications project (for example, a scientific poster or an educational slide deck)
Qualification
Required
Strong written and verbal communication skills, with the ability to collaborate effectively in a team environment
Ability to thrive in a fast-paced environment, build new connections, and contribute to diverse projects
Enthusiasm for contributing to Kailera's mission and alignment with our core values: courageous, collaborative, compassionate, and committed
Bachelor's degree candidates who have completed 2+ years of coursework; candidates who have completed scientific coursework are encouraged to apply
Preferred
Master's coursework preferred
Benefits
Comprehensive health coverage
Monthly wellness stipend
Flexible time off
Paid holidays
Year-end shutdown
Generous 401(k) match
Tuition reimbursement
Commuter benefits
Disability and life insurance
Annual bonus opportunities
Equity grants
Company
Kailera Therapeutics
Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.
Founded in 2024
51-200 employees
Funding
Current Stage
Growth StageTotal Funding
$1BKey Investors
Bain Capital Private Equity
2025-10-14Series B· $600M
2024-10-01Series A· $400M
Leadership Team
Ronald Renaud
President & CEO
Paul Burgess
COO & CBO
Recent News
2026-01-05
2025-12-24
2025-12-17
Company data provided by crunchbase